The expert review committee of the Ohio Medical Marijuana Control Program has dropped its support to approve medical marijuana for the treatment of autism and anxiety in the state.
It was last fall when the committee had recommended that the State Medical Board of Ohio approve marijuana to treat those conditions.
It was after hearing from a panel of experts on Wednesday that the committee reversed its decision and decided that research on the use of marijuana to treat autism and anxiety is inconclusive.
“At this point, approval seems premature,” said medical board President Michael Schottenstein. He is also a member of the review committee. “There should be a consensus, and it’s clear that we don’t have that.”
Marijuana is currently approved to treat 21 medical conditions in Ohio, including chronic pain and post-traumatic stress disorder.
